Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules-Reference-Cited by-同舟云学术

Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules

Published:2017-12 Issue:52 Volume:35 Page:7283-7291
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bandyopadhyay Ananda S.,Asturias Edwin J.,O'Ryan Miguel,Oberste M. Steven,Weldon William,Clemens Ralf,Rüttimann Ricardo,Modlin John F.,Gast Chris

Funder

Bill & Melinda Gates Foundation (BMGF)

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference41 articles.

1. Global Polio Eradication Initiative. Polio this week as of 15 February 2017. http://polioeradication.org/polio-today/polio-now/this-week/ [accessed 16.02.17].

2. Global Polio Eradication Initiative. Polio Eradication & Endgame Strategic Plan 2013-2018. Geneva, Switzerland: World Health Organization; 2013. http://polioeradication.org/wp-content/uploads/2016/07/PEESP_EN_A4.pdf [accessed 16.02.17].

3. Polio vaccination: past, present and future;Bandyopadhyay;Future Microbiol,2015

4. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus;Herremans;J Immunol,1999

5. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination;Wright;J Infect Dis,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polio Eradication: Status, Struggles and Strategies;Pediatric Infectious Disease Journal;2024-04-02

2. Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic;The Lancet Infectious Diseases;2023-12

3. Does IPV Boost Intestinal Immunity among Children under Five Years of Age? An Experience from Pakistan;Vaccines;2023-09-01

4. Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants;Vaccine;2023-06

5. Evaluation of the safety, immunogenicity, and faecal shedding of novel oral polio vaccine type 2 in healthy newborn infants in Bangladesh: a randomised, controlled, phase 2 clinical trial;The Lancet;2023-01